This case study is based on actual matters handled by Song Law Firm. To protect client confidentiality, all identifying information — including names, nationality, affiliations, and specific dates — has been anonymized and generalized. The narrative consolidates common patterns from multiple cases so that no single matter is identifiable, and certain facts have been altered for confidentiality. Song Law Firm makes no guarantee or promise of any particular outcome. This document is not advertising that promises results. Visa and immigration outcomes vary substantially based on USCIS review, facts, evidence, and policy changes; past results do not guarantee future outcomes. For specific legal advice, please consult an attorney directly.
Client Profile
Korean-American healthcare and clinical research professionals in their 30s–40s, holding either a PhD or medical doctorate (MD/MD-PhD), engaged in clinical research or public health programs in the United States. Some were affiliated with university medical centers or research hospitals as faculty, research fellows, or attending physicians, while others worked in healthcare data analytics, drug/medical device evaluation, or public health policy. This pattern consolidates common profiles among healthcare NIW cases handled by Song Law Firm.
Background
The client group contributed — directly or indirectly — to improving patient treatment outcomes, public health data analysis, and evaluation of new drugs and medical devices. They sought NIW because the U.S. national interest argument for healthcare/clinical research could be more concretely framed than for general STEM cases, while also wanting to bypass the PERM step.
Legal Framework
The legal basis is EB-2 NIW under INA § 203(b)(2)(B), and the Matter of Dhanasar 3-prong standard applies. In healthcare, the prong 1 “national importance” element can be argued by leveraging public health priorities expressly stated by U.S. federal agencies (HHS, NIH, CDC, FDA, etc.), creating a relatively favorable evidentiary structure.
Song Law Firm Strategy
Tailored to clinical sector characteristics, Song Law Firm applied the following strategy.
First, we organized the client’s clinical publications and patient treatment outcome data, and built the prong 2 well-positioned argument with citations of clinical guidelines or treatment protocol changes.
Second, recognizing that patient confidentiality and HIPAA constraints are critical in clinical research, we ensured evidence presentation complied with deidentification standards.
Third, we used U.S. federal public health policies and goals as backbone of the national importance argument, with specific demonstration that the client’s clinical contributions aligned with those policies.
Fourth, we secured a structured set of expert opinion letters from medical faculty, clinical research centers, and public health authorities.
Process and Timeline
Because of patient confidentiality concerns, evidence collection and expert letter procurement required additional time. The I-140 (EB-2/NIW) petition was filed with USCIS, with Premium Processing utilized for time-sensitive cases. Regular processing varied with USCIS policy.
Outcome
The I-140 NIW petition received an Approval Notice (Form I-797) from USCIS. Subsequent steps proceeded through I-485 Adjustment of Status or Consular Processing.
Key Takeaways
In the healthcare sector, anchoring the national importance argument to U.S. federal public health policy and demonstrating tangible contribution to patient treatment outcomes work effectively. Compliance with patient confidentiality and HIPAA during evidence preparation is essential — both for legal compliance and for credibility before adjudicators.
Consultation — Four Channels
📞 (201) 461-0031
✉ office@songlawfirm.com
🌐 songlawfirm.com/consultation/
📍 Parker Plaza, 400 Kelby St, 19th Floor, Fort Lee, NJ 07024
⚠ Notice
This case study is based on actual matters handled by Song Law Firm. To protect client confidentiality, all identifying information — including names, nationality, affiliations, and specific dates — has been anonymized and generalized. The narrative consolidates common patterns from multiple cases so that no single matter is identifiable, and certain facts have been altered for confidentiality.
Song Law Firm makes no guarantee or promise of any particular outcome, and this document is not advertising that promises results. Visa and immigration outcomes vary substantially based on USCIS review, facts, evidence, and policy changes; past results do not guarantee future outcomes. For specific immigration legal advice, please consult an attorney directly.
